28 Results for "

Tofacitinib

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "Tofacitinib" in MCE Product Catalog:

100
100 Publications Verification
Cat. No.: HY-40354
CAS No.: 477600-75-2
Synonyms: Tasocitinib; CP-690550
Target:  

JAK Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
100
100 Publications Verification
Cat. No.: HY-40354A
CAS No.: 540737-29-9
Synonyms: Tasocitinib citrate; CP-690550 citrate
Tofacitinib citrate is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136336
CAS No.: 1640971-51-2
Purity:  99.59%
Target:  

JAK

Research Areas:  

Others

Tofacitinib metabolite-1 is a metabolite of Tofacitinib and a JAK3 inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-40354AR
CAS No.: 540737-29-9
Synonyms: Tasocitinib citrate (Standard); CP-690550 citrate (Standard)
Tofacitinib (citrate) (Standard) is the analytical standard of Tofacitinib (citrate). This product is intended for research and analytical applications. Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC50s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities.
loading...
    loading...
Cat. No.: HY-40354D
CAS No.: 1092578-46-5
Target:  

JAK

Research Areas:  

Inflammation/Immunology

(3R,4S)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
loading...
    loading...
Cat. No.: HY-40354C
CAS No.: 1092578-47-6
Target:  

JAK

Research Areas:  

Inflammation/Immunology

(3S,4S)-Tofacitinib is the less active S-enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
loading...
    loading...
Cat. No.: HY-40354R
CAS No.: 477600-75-2
Synonyms: Tasocitinib (Standard); CP-690550 (Standard)
Tofacitinib (Standard) is the analytical standard of Tofacitinib. This product is intended for research and analytical applications. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
Cat. No.: HY-40354S
CAS No.: 2256762-71-5
Synonyms: Tasocitinib-13C3; CP-690550-13C3
Tofacitinib- 13C3 is the 13C-labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
Cat. No.: HY-21273
CAS No.: 384338-23-2
Target:  

Drug Intermediate

Research Areas:  

Others

Tofacitinib impurity 4 is an impurity of Tofacitinib (HY-40354).
loading...
    loading...
Cat. No.: HY-40354B
CAS No.: 1092578-48-7
Target:  

JAK

Research Areas:  

Inflammation/Immunology

(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
loading...
    loading...
Cat. No.: HY-40354AS
CAS No.: 2701680-77-3
Synonyms: Tasocitinib-d3 citrate; CP-690550-d3 citrate
Tofacitinib-d3 (citrate) is deuterium labeled Tofacitinib (citrate). Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC50s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities.
loading...
    loading...
Cat. No.: HY-40354S1
Synonyms: Tasocitinib-13C3,15N; CP-690550-13C3,15N
Tofacitinib- 13C3, 15N (Tasocitinib- 13C3, 15N) is 13C and 15N labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
Cat. No.: HY-151259
CAS No.: 2232890-81-0
Target:  

JAK

Research Areas:  

Cancer

TK4b is a dual JAK2/3 inhibitor with human JAK2 and JAK3 IC50s of 19.40 nM and 18.42 nM, respectively. TK4b can be used for the research of leukemia and myelofibrosis .
loading...
    loading...
Cat. No.: HY-40352A
CAS No.: 1260614-73-0
Target:  

Drug Intermediate

Research Areas:  

Others

Tofacitinib impurity 6 is an impurity of Tofacitinib (HY-40354).
loading...
    loading...
Cat. No.: HY-145829
Target:  

JAK Apoptosis

Research Areas:  

Inflammation/Immunology

Tofacitinib precursor-1 is an effective and oral active precursor to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib precursor-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib precursor-1 is a potential drug candidate for the research of ulcerative colitis .
loading...
    loading...
Cat. No.: HY-40354S3
Synonyms: Tasocitinib-13C; CP-690550-13C
Tofacitinib- 13C (Tasocitinib- 13C) is 13C labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
Cat. No.: HY-40354S5
Synonyms: Tasocitinib-d3; CP-690550-d3
Tofacitinib-d3 (Tasocitinib-d3) is deuterium labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
Cat. No.: HY-40354S2
Synonyms: Tasocitinib-13C,d3; CP-690550-13C,d3
Tofacitinib- 13C,d3 (Tasocitinib- 13C,d3) is 13C labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
loading...
    loading...
Cat. No.: HY-78558
CAS No.: 1675248-19-7
Synonyms: 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
Target:  

Drug Intermediate

Research Areas:  

Others

Tofacitinib Impurity T (3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-123289
CAS No.: 1243290-37-0
Target:  

JAK

Research Areas:  

Inflammation/Immunology

CP-690550A is an analogue of Tofacitinib (HY-40354). CP-690550A is a dual inhibitor of JAK2 and JAK3 .
loading...
    loading...